IBI3002
History
Earliest recorded event: Jul 14, 2025. This timeline shows events collected by Eczema Radar and may not include the treatment’s full history. Study details reflect the latest registry record available here.
- Feb 6, 2026Phase 2 trial startedA Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic Dermatitis ClinicalTrials.gov NCT07399067
- Jul 14, 2025Phase 1 trial startedA Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis ClinicalTrials.gov NCT07015762
Sources
- Trials